AmerisourceBergen

AmerisourceBergen, which rebranded to Cencora in August 2023, is a global pharmaceutical solutions organisation. Its work spans pharmaceutical distribution, manufacturer support, provider services and animal health, with the stated aim of improving access to healthcare for people and animals. The company employs more than 44,000 people and operates from over 1,300 locations worldwide.

The business is organised around several service lines. Pharmaceutical wholesale and specialty distribution moves medications to their destinations; the company reports that it serves 100% of U.S. hospitals. Manufacturer support services help pharmaceutical innovators optimise market access to therapies across the value chain. Provider services cover specialty pharmacies, haemophilia centres and home healthcare companies, while animal health solutions serve animal health providers worldwide.

Technical domains at the company include pharmaceutical distribution, specialty distribution, supply chain logistics, market access optimisation, wholesale pharmaceutical services and animal health solutions. AmerisourceBergen is a public company and ranks #11 on the Fortune 500, with annual revenue of over $200 billion.

Operations are concentrated in the United States but extend globally. Industry verticals touched by the organisation include pharmaceuticals, healthcare, hospitals, specialty pharmacy, home healthcare, animal health, pharmaceutical manufacturing and wholesale distribution.